TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$93.91+1.70 (+1.84%)
Close on Nov 17, 2026Market cap $3.26BP/E 24.4Yield 0.00%
TransMedics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
TransMedics's EV/EBITDA was 23.2× on Nov 11, 2026, against 37.4× a year earlier. Over the last 2 years it ranged from 14.5× to 385.1×, with a median of 35.0×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 23.2× | −7.3 |
| 2025 | Dec 31, 2025 | 30.4× | −5.4 |
| 2024 | Dec 31, 2024 | 35.9× | – |
See a number that looks wrong?